Buspirone hydrochloride 15 MG Oral Tablet — RxCUI 866018
RxNorm drug concept · Semantic clinical drug
RxCUI 866018
Semantic clinical drug · SCD
● Current RxNorm concept 163 FDA products
433 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI866018
Official nameBuspirone hydrochloride 15 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbuspirone hydrochloride 15 MG (buspirone 13.7 MG) Oral Tablet; busPIRone HCl 15 MG Oral Tablet
FDA products mapped163
Package NDCs mapped433
Reported Medicaid activity (SDUD)5,177,856 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Buspirone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Unlike some anti-anxiety medicines that work quickly, buspirone tends to build up its effect gradually. Most people don't feel the full benefit for a few weeks. That can feel frust...
- How long does it take for buspirone to start working?
- Either can work, but the key is to be consistent. Food increases how much buspirone your body absorbs, so if you switch back and forth — sometimes eating before it, sometimes not —...
- Should I take buspirone with food or on an empty stomach?
🕸️ Concept Web — How Buspirone hydrochloride 15 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Buspirone hydrochloride 15 MG Oral Tablet
RxCUI 866018 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Buspirone
1827IN -
Buspirone hydrochloride
203116PIN
-
Buspirone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Buspar
154990BN
-
Buspar
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Buspirone Oral Tablet
371164SCDF -
Buspirone hydrochloride Oral Tablet
2648765SCDFP -
Buspirone Oral Product
1151372SCDG -
Buspirone Pill
1151373SCDG -
Buspirone hydrochloride Oral Product
2660696SCDGP -
Buspirone hydrochloride Pill
2662536SCDGP -
Buspirone Oral Tablet [Buspar]
367701SBDF -
Buspirone hydrochloride Oral Tablet [Buspar]
2654173SBDFP - +5 more in this family
-
Buspirone Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Buspirone hydrochloride 15 MG
866017SCDC -
Buspirone hydrochloride 15 MG Oral Tablet [Buspar]
866088SBD -
Buspirone hydrochloride 15 MG [Buspar]
866087SBDC
-
Buspirone hydrochloride 15 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Buspirone hydrochloride 15 MG
SCDC · 866017 -
Buspirone Oral Tablet
SCDF · 371164 -
Buspirone hydrochloride Oral Tablet
SCDFP · 2648765 -
Buspirone Oral Product
SCDG · 1151372 -
Buspirone Pill
SCDG · 1151373 -
Buspirone hydrochloride Oral Product
SCDGP · 2660696 -
Buspirone hydrochloride Pill
SCDGP · 2662536
Brand-Name Concepts
-
Buspirone hydrochloride 15 MG Oral Tablet [Buspar]
SBD · 866088 -
Buspirone hydrochloride 15 MG [Buspar]
SBDC · 866087 -
Buspirone Oral Tablet [Buspar]
SBDF · 367701 -
Buspirone hydrochloride Oral Tablet [Buspar]
SBDFP · 2654173 -
Buspar Oral Product
SBDG · 1168700 -
Buspar Pill
SBDG · 1168701 -
Buspar
BN · 154990
📦 FDA Products & Package NDCs
163 products · 433 package NDCs
433 package NDCs map to RxCUI 866018 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-0053-01 | 100 TABLET in 1 BOTTLE (0093-0053-01) | Buspirone Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2002-02-28 |
| 00093-0053-05 | 500 TABLET in 1 BOTTLE (0093-0053-05) | Buspirone Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2002-03-01 |
| 00093-0054-01 | 100 TABLET in 1 BOTTLE (0093-0054-01) | Buspirone Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2002-02-28 |
| 00093-0054-05 | 500 TABLET in 1 BOTTLE (0093-0054-05) | Buspirone Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2002-03-01 |
| 00093-1003-01 | 100 TABLET in 1 BOTTLE (0093-1003-01) | Buspirone Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2002-03-01 |
| 00093-1003-05 | 500 TABLET in 1 BOTTLE (0093-1003-05) | Buspirone Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2002-03-01 |
| 00093-5200-05 | 500 TABLET in 1 BOTTLE (0093-5200-05) | Buspirone Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2004-03-26 |
| 00093-5200-06 | 60 TABLET in 1 BOTTLE (0093-5200-06) | Buspirone Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2004-03-26 |
| 00378-1140-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0378-1140-01) | Buspirone Hydrochloride | Mylan Pharmaceuticals Inc. | 2002-03-21 |
| 00378-1140-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0378-1140-05) | Buspirone Hydrochloride | Mylan Pharmaceuticals Inc. | 2002-03-21 |
| 00378-1150-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0378-1150-05) | Buspirone Hydrochloride | Mylan Pharmaceuticals Inc. | 2002-03-21 |
| 00378-1165-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0378-1165-05) | Buspirone Hydrochloride | Mylan Pharmaceuticals Inc. | 2001-03-29 |
| 00378-1165-80 | 180 TABLET in 1 BOTTLE, PLASTIC (0378-1165-80) | Buspirone Hydrochloride | Mylan Pharmaceuticals Inc. | 2001-03-29 |
| 00378-1165-91 | 60 TABLET in 1 BOTTLE, PLASTIC (0378-1165-91) | Buspirone Hydrochloride | Mylan Pharmaceuticals Inc. | 2001-03-28 |
| 00378-1175-91 | 60 TABLET in 1 BOTTLE, PLASTIC (0378-1175-91) | Buspirone Hydrochloride | Mylan Pharmaceuticals Inc. | 2001-08-01 |
| 00615-7689-05 | 15 TABLET in 1 BLISTER PACK (0615-7689-05) | Buspirone Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2022-11-30 |
| 00615-7689-39 | 30 TABLET in 1 BLISTER PACK (0615-7689-39) | Buspirone Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2013-01-24 |
| 00615-7714-05 | 15 TABLET in 1 BLISTER PACK (0615-7714-05) | Buspirone Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2022-11-21 |
| 00615-7714-30 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-7714-30) / 5 TABLE... | Buspirone Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2012-04-23 |
| 00615-7714-39 | 30 TABLET in 1 BLISTER PACK (0615-7714-39) | Buspirone Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2012-04-23 |
| 00615-7718-05 | 15 TABLET in 1 BLISTER PACK (0615-7718-05) | Buspirone Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2022-11-10 |
| 00615-7718-28 | 28 TABLET in 1 BLISTER PACK (0615-7718-28) | Buspirone Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-04-19 |
| 00615-7718-39 | 30 TABLET in 1 BLISTER PACK (0615-7718-39) | Buspirone Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2012-08-07 |
| 00904-6899-61 | 100 BLISTER PACK in 1 CARTON (0904-6899-61) / 1 TABLET in 1... | Buspirone hydrochloride | Major Pharmaceuticals | 2014-05-03 |
| 11788-0057-01 | 100 TABLET in 1 BOTTLE (11788-057-01) | Buspirone hydrochloride | AiPing Pharmaceutical, Inc. | 2025-09-26 |
| 11788-0057-05 | 500 TABLET in 1 BOTTLE (11788-057-05) | Buspirone hydrochloride | AiPing Pharmaceutical, Inc. | 2025-09-26 |
| 11788-0058-01 | 100 TABLET in 1 BOTTLE (11788-058-01) | Buspirone hydrochloride | AiPing Pharmaceutical, Inc. | 2025-09-26 |
| 11788-0059-01 | 100 TABLET in 1 BOTTLE (11788-059-01) | Buspirone hydrochloride | AiPing Pharmaceutical, Inc. | 2025-09-26 |
| 11788-0059-05 | 500 TABLET in 1 BOTTLE (11788-059-05) | Buspirone hydrochloride | AiPing Pharmaceutical, Inc. | 2025-09-26 |
| 11788-0060-01 | 100 TABLET in 1 BOTTLE (11788-060-01) | Buspirone hydrochloride | AiPing Pharmaceutical, Inc. | 2025-09-26 |
| 11788-0060-05 | 500 TABLET in 1 BOTTLE (11788-060-05) | Buspirone hydrochloride | AiPing Pharmaceutical, Inc. | 2025-09-26 |
| 11788-0061-05 | 500 TABLET in 1 BOTTLE (11788-061-05) | Buspirone hydrochloride | AiPing Pharmaceutical, Inc. | 2025-09-26 |
| 11788-0061-60 | 60 TABLET in 1 BOTTLE (11788-061-60) | Buspirone hydrochloride | AiPing Pharmaceutical, Inc. | 2025-09-26 |
| 16729-0200-01 | 100 TABLET in 1 BOTTLE (16729-200-01) | Buspirone Hydrochloride | Accord Healthcare Inc. | 2016-12-15 |
| 16729-0200-16 | 500 TABLET in 1 BOTTLE (16729-200-16) | Buspirone Hydrochloride | Accord Healthcare Inc. | 2016-12-15 |
| 16729-0201-01 | 100 TABLET in 1 BOTTLE (16729-201-01) | Buspirone Hydrochloride | Accord Healthcare Inc. | 2016-11-14 |
| 16729-0202-01 | 100 TABLET in 1 BOTTLE (16729-202-01) | Buspirone Hydrochloride | Accord Healthcare Inc. | 2016-12-15 |
| 16729-0202-16 | 500 TABLET in 1 BOTTLE (16729-202-16) | Buspirone Hydrochloride | Accord Healthcare Inc. | 2016-12-15 |
| 16729-0203-01 | 100 TABLET in 1 BOTTLE (16729-203-01) | Buspirone Hydrochloride | Accord Healthcare Inc. | 2016-12-15 |
| 16729-0203-12 | 60 TABLET in 1 BOTTLE (16729-203-12) | Buspirone Hydrochloride | Accord Healthcare Inc. | 2016-12-15 |
| 16729-0289-12 | 60 TABLET in 1 BOTTLE (16729-289-12) | Buspirone Hydrochloride | Accord Healthcare Inc. | 2016-12-15 |
| 23155-0023-01 | 100 TABLET in 1 BOTTLE (23155-023-01) | Buspirone Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-09-18 |
| 23155-0023-05 | 500 TABLET in 1 BOTTLE (23155-023-05) | Buspirone Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2018-09-20 |
| 23155-0023-10 | 1000 TABLET in 1 BOTTLE (23155-023-10) | Buspirone Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2018-09-20 |
| 23155-0024-01 | 100 TABLET in 1 BOTTLE (23155-024-01) | Buspirone Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-09-18 |
| 23155-0024-05 | 500 TABLET in 1 BOTTLE (23155-024-05) | Buspirone Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2018-09-20 |
| 23155-0024-10 | 1000 TABLET in 1 BOTTLE (23155-024-10) | Buspirone Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2018-09-20 |
| 23155-0025-01 | 100 TABLET in 1 BOTTLE (23155-025-01) | Buspirone Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2018-09-20 |
| 23155-0025-05 | 500 TABLET in 1 BOTTLE (23155-025-05) | Buspirone Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2018-09-20 |
| 23155-0025-06 | 60 TABLET in 1 BOTTLE (23155-025-06) | Buspirone Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-09-18 |
Observed labelers:
Bryant Ranch Prepack (39) ·
Proficient Rx LP (35) ·
Asclemed USA, Inc. (33) ·
Aurobindo Pharma Limited (23) ·
Zydus Lifesciences Limited (22) ·
Zydus Pharmaceuticals USA Inc. (22)
· +36 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.